Widespread cefiderocol heteroresistance in carbapenem-resistant Gram-negative pathogens-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Widespread cefiderocol heteroresistance in carbapenem-resistant Gram-negative pathogens

Published:2021-05 Issue:5 Volume:21 Page:597-598
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Choby Jacob E,Ozturk Tugba,Satola Sarah W,Jacob Jesse T,Weiss David S

Funder

National Institutes of Health

Centers for Disease Control and Prevention

U.S. Department of Veterans Affairs

Burroughs Wellcome Fund

Cystic Fibrosis Foundation

Health Services Research and Development

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference5 articles.

1. Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial;Bassetti;Lancet Infect Dis,2021

2. Colistin heteroresistance is largely undetected among carbapenem-resistant Enterobacterales in the United States;Band;mBio,2021

3. Antibiotic failure mediated by a resistant subpopulation in Enterobacter cloacae;Band;Nat Microbiol,2016

4. Carbapenem-resistant Klebsiella pneumoniae exhibiting clinically undetected colistin heteroresistance leads to treatment failure in a murine model of infection;Band;mBio,2018

5. In vitro activity of the siderophore cephalosporin, cefiderocol, against carbapenem-nonsusceptible and multidrug-resistant isolates of Gram-negative bacilli collected worldwide in 2014 to 2016;Hackel;Antimicrob Agents Chemother,2018

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of cefiderocol and colistin-based regimens for the treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii: a systematic review with meta-analysis and trial sequential analysis;BMC Infectious Diseases;2024-09-13

2. Cefiderocol for the Treatment of Infections by VIM-Type-Producing Gram-Negative Bacteria;Antibiotics;2024-09-12

3. Frequency of cefiderocol heteroresistance among patients treated with cefiderocol for carbapenem-resistant Acinetobacter baumannii infections;JAC-Antimicrobial Resistance;2024-09-03

4. Commercially available tests for determining cefiderocol susceptibility display variable performance in the Achromobacter genus;Annals of Clinical Microbiology and Antimicrobials;2024-08-22

5. Hetero-antagonism of avibactam and sulbactam with cefiderocol in carbapenem-resistant Acinetobacter spp.;Microbiology Spectrum;2024-08-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3